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ABSTRACT: Steroid-sensitive nephrotic syndrome (SSNS) and focal segmental
glomerulosclerosis (FSGC) share immunologic and pathogenetic features. We studied  93 Brazilian
patients (46 with SSNS and 47 with FSGC) and 104 control subjects with the objective of
characterizing the immunogenetic profile of these varieties of idiopathic nephrotic syndrome.
HLA-A, -B, and -DR antigens were typed using a complement-dependent microlymphocytotoxicity
assay. No significanty association was observed with HLA-A or -B antigens in either group; however,
HLA-B7 and -B12 antigens were increased in SSNS patients. HLA-DR7, -DR1 and the combination
of HLA-DR1/DR7 antigens were significantly increased in the total group of patients with SSNS
compared to controls or to FGSC patients. The study of only Caucasoid individuals revealed  that
HLA-DR7 antigen remained significantly increased in SSNS patients. The HLA-B7/DR7  haplotype
was siginificantly increased in both SSNS and FSGC patients.  Although the Brazilian population
is highly miscigenated, the same antigen (HLA-DR7) which confers susceptibility to SSNS in
other Caucasian population is still prevalent in this series.
UNITERMS: HLA Antigens. Nephrotic Syndrome. Glomerulosclerosis, Focal.
1. INTRODUCTION
The etiology and pathogenesis of idiopathic
nephrotic syndrome remain obscure. Two major
varieties are described: minimal change disease (MCD)
and focal segmental glomerulosclerosis (FSGC)(1).
MCD, also designated steroid-sensitive nephrotic
syndrome (SSNS), is more common in children,
responds to glucocorticoid therapy(2). Although FSGC
can affect patients at any age, most cases are seen
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between 25 and 35 years(3). Since there is the possibility
of transition from MCD to FSGC, it has been
hypothesized that these diseases are two extremes of
one spectrum and may represent different stages of a
single disease(1,4). It is also assumed that both
conditions share immunopathogenetic mechanisms, i.e.,
association with diseases showing well-established im-
munologic features, response to glucocorticoids,
alkylating agents and cyclosporine, increased incidence
of atopic disorders in SSNS and recurrence of
nephrotic syndrome after renal transplantation in
FSGC(1,2,5) . In addition, the diseases associated with
idiopathic nephrotic syndrome share several immunological
alterations such as the presence of circulating factors
which promote proteinuria and increased serum levels of
autoreactive IgA antibodies and interleukins(5/10). In family
studies, the presence of multiplex cases of idiopathic
nephrotic syndrome sharing HLA antigens has suggested
the influence of immunogenetic markers(2,11).
Immunogenetic studies of unrelated patients conducted
on distinct populations have shown associations with
HLA class I (HLA-B8, –B12) and class II (HLA-
DR7) antigens for idiopathic nephrotic syndrome
patients irrespective of the variant FSGC(12/17). In order
to identify the immunogenetic profile in a Brazilian
population from the Northeast region of the State of
São Paulo presenting with SSNS or FSGC, and to
address the question of whether SSNS and FSGC share
immunogenetic markers, we typed HLA- (A,-B and -
DR) antigens in 2 series of patients presenting with
one of these two conditions. Considering that the
Brazilian population is highly miscegenated, we further
compared HLA frequency between Caucasoid patients
(SSNS and  FSGC) and controls.
2. PATIENTS AND METHODS
2.1. Subjects
Forty-six (29 males) steroid-sensitive nephrotic
syndrome patients, age of onset 1-10 years (median =
3), 38 Caucasoids (83%), 5 Mulattoes (11%) and 3
Negroes (6%), seen at the Division of Pediatric
Nephrology, School of  Medicine of Ribeirão Preto,
University of São Paulo, Brazil, from 1986 to 1995,
were studied. A total of 26 children were diagnosed
before the age of 4 and 20 after that age. The diagnosis
of SSNS was performed on the basis of clinical and
laboratory evidence of nephrotic syndrome, i.e, edema
and proteinuria > 40 mg/hour/m2/day, and serum
albumin < 3.0 g/dl. Neither macroscopic hematuria nor
elevation of arterial pressure was observed. All patients
responded to treatment with 60 mg/m2/day predisone
for 4-6 weeks, presenting remission of clinical and
laboratory features of nephrotic syndrome. After a
follow-up period of 5 years, 148 relapses, ranging from
1 to 11 (median=3 relapses), occurred in 38 (83%) of
these patients, and 19 patients were steroid-dependent.
These patients who responded to the treatment with
prednisone were included in the SSNS group.
Forty-seven (29 males) patients with idiopathic
focal segmental glomerulosclerosis, aged 12-74 years
(median = 31), 37 Caucasoids (79%), 5 Mulattoes
(12%) and 4 Negroes (9%), seen at the Division of
Nephrology, School of Medicine of Ribeirão Preto,
University of São Paulo, Brazil, from 1986 to 1995,
were also studied. The clinical/laboratory features of
the patients can be summarized as follows: a) all pa-
tients presented nephrotic syndrome; b) 14 (30%) had
normal blood pressure and creatinine clearance; c) 18
(38%) presented hypertension and low creatinine clear-
ance; d) 15 (32%) exhibited only hypertension or only
low creatinine clearance; e) relapses were observed
in 16 patients (34%). All patients underwent renal bi-
opsy (light plus immunofluorescence microscopy)
which was characteristic of FSGS. Other underlying
diseases were excluded. Treatment with prednisone
1.0 mg/kg body weight, or alkylating agents
(cyclosphosphamide or chlorambucil) combined with
low doses of prednisone was followed by complete
remission (38%) or partial remission (17%) or absence
of remission (29%). Five patients (10%) had end-stage
renal disease and 2 (4%) were on enalapril treatment.
A total of 104 control individuals, 85 Caucasoids
(82%), 14 Mulattoes (14%) and 4 Negroes (4%), from
the same geographical area and presumably of similar
ethnic background, were also typed for HLA antigens.
2.2. HLA antigens
Mononuclear peripheral blood cells were isolated
using a Ficoll-Hypaque gradient at a density of 1.077
g/ml. B-lymphocytes were recovered by adherence
to nylon wool (Robbins Scientific - USA). HLA typing
was performed using a complement-dependent
microlymphocytotoxicity assay(18). The following
antisera were used: HLA - A(A1, A2, A3, A9, A10,
A11, A19, A23, A24, A25, A26, A28, A29, A30, A31,
A32, A33, A34, A36); HLA-B(B5, B7, B8, B12, B13,
B14, B15, B16, B17, B18, B21, B22, B27, B35, B37,
B38, B39, B40, B41, B42, B44, B45, B47, B48, B49,
B50, B51, B52, B54, B55, B56, B60, B61, B64, B65,
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B70) and HLA - DR (DR1 - DR10), DR52, DR53,
from France Transplant (France) and Biotest
(Germany). Complement was obtained from a pool of
normal rabbit sera.
2.3. Statistical analysis
Comparisons of HLA frequencies between
patients and controls were estimated using the two-
tailed exact Fisher test, with corrections of p value
(pc) according to the number of HLA specificities
tested and the number of comparisons. Differences
were considered significant only when pc< 0.05.
Relative risk (RR), which indicates how many times
more often the disease occurs in individuals with the
HLA marker compared to those without it was
calculated. A relative risk greater than 1 is seen when
the antigen is more frequent in patients than in controls
and indicates an increased risk to develop the disease.
When the RR is greater than 1 the etiologic fraction
(EF) can be estimated and it is also called the
attributable risk at the population level, i. e., the EF
indicates how much the HLA marker under study
contributes to the development of the disease at
population level (19) .
3. RESULTS
The frequency of HLA-A, -B, and -DR antigens
observed among patients (SSNS and FSGS) and
controls is shown in Tables I-III. In addition, the
frequency of HLA antigens, studying only Caucasoid
patients and controls, is also shown in these tables.
No significant HLA-A or -B association with
SSNS or FSGS was found (Tables I and II).
Compared to the respective control group,
HLA-DR7 antigen was significantly increased in total
group and Caucasoid patients presenting with SSNS
(pc = 0.016 and 0.017, respectively), conferring RR of
4.31 and 4.29, respectively, and an EF of 0.4 for both
groups. HLA-DR1 antigen was significantly increased
only in the total group of SSNS patients
(pc = 0.036), conferring an RR of 3.83 and a EF of
0.45 (Table III). Comparisons within subsets of SSNS
(no relapses, infrequent relapses or frequent relapses,
and age of onset < 4 years or >4 years) did not show
significant differences. In the SSNS group as a whole,
the combination of both HLA-DR1/DR7 antigens oc-
curred in 15 of 46 patients and in only 3 of 104 con-
trols (pc < 0.001, RR = 15.30, EF = 0.31).
Table I - Frequency (%) of HLA-A antigens in patients with steroid-sensitive nephrotic syndrome
(SSNS), focal segmental glomerulosclerosis (FSGS), and control individuals, regarding all ethnic
groups (total) and only the Caucasoid (Cauc) group
SSNS FSGS CONTROLHLA-A Total
(n=46)
Cauc
(n=38)
Total
(n=47)
Cauc
(n=37)
Total
(n=104)
Cauc
(n=85)
A1
A2
A3
A9
A10
A11
A23 (9)*
A25 (10)
A28
A29 (19)
A30 (19)
A31 (19)
A32 (19)
A33 (19)
A34 (10)
A36
39
46
24
37
2
17
-
-
20
2
-
-
-
-
-
-
42
39
26
37
3
18
-
-
16
3
-
-
-
-
-
-
32
45
17
21
4
10
6
2
21
4
6
-
-
6
2
4
38
43
13
18
5
5
8
-
22
5
8
-
-
8
-
5
24
48
12
24
17
16
3
4
10
10
4
4
5
2
-
-
22
52
12
18
16
16
3
3
9
8
3
3
3
1
-
-
* (    ) splits of HLA-A
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Table II - Frequency (%) of HLA-B antigens in patients with steroid-sensitive nephrotic  syndrome
(SSNS), focal segmental glomerulosclerosis (FSGS), and control individuals, regarding all ethnic
groups (total) and only the Caucasoid (Cauc) group
SSNS FSGS CONTROL
HLA-B Total
(n=46)
Cauc
(n=38)
Total
(n=47)
Cauc
(n=37)
Total
(n=104)
Cauc
(n=85)
B5
B7
B8
B12
B13
B14
B15
B16
B17
B18
B21
B22
B27
B35
B37
B38 (16)*
B39 (16)
B40
B41
B44 (12)
B45 (12)
B65 (14)
28
39
6
37
4
11
2
-
-
-
19
2
2
15
-
-
-
-
5
-
-
-
21
37
8
42
5
10
3
-
-
-
24
3
-
5
-
-
-
-
5
-
-
-
28
23
27
17
10
6
-
-
8
8
4
2
2
8
2
-
2
4
-
10
4
2
32
27
24
11
11
8
-
-
8
8
3
3
3
11
3
-
-
-
-
13
5
3
13
15
15
15
11
16
7
1
4
19
16
2
2
22
1
1
2
2
2
7
2
-
13
16
15
19
11
18
6
1
5
21
19
2
2
15
1
1
2
-
1
6
1
-
* (    ) splits of HLA-B
The comparisons of HLA-DR antigen fre-
quency between patients with FSGS (total group or
only Caucasoid) and controls were all non-significant;
however, the comparison of these frequencies be-
tween the total group of SSNS and FSGS patients
showed  an  increased  frequency of both  HLA-
DR1 and HLA-DR7 in SSNS patients (pc = 0.008
and 0.026, respectively). Estimation of RR and EF
for these specificities were 5.75, 0.50 and 5.32, 0.42;
respectively.
Considering the HLA-B/DR haplotypes more
frequently associated with HLA-DR7 and DR1 in the
Brazilian population, i.e., HLA-B7/DR7, B12/DR7,
B12/DR1, B14/DR1, B5/DR1(20), haplotype HLA-B7/
DR7 was significantly increased in SSNS patient (to-
tal group and only Caucasoids), and in FSGS (Table
III). The susceptibility conferred by each of HLA-B7
or HLA-DR7 antigen was independent for SSNS
patients (Table IV). The haplotypes HLA-B12/DR7
and HLA-B12/DR1 were also significantly increased
in SSNS patients from the total group and from the
Caucasoid group (Table III).
51
HLA and idiopathic nephrotic syndrome
Table III - Frequency (%) of HLA-DR antigens and HLA-B/DR haplotypes in patients with steroid-
sensitive nephrotic syndrome (SSNS), focal segmental glomerulosclerosis (FSGS), and control
individuals, regarding all ethnic groups (total) and only the Caucasoid (Cauc) group. The corrected p
value (pc), the relative risk (RR) and the etiologic fraction (EF) were estimated by comparing patients
from each group with respective controls
SSNS FSGS CONTROL
HLA-DR Total
(n=46)
Cauc
(n=38)
Total
(n=47)
Cauc
(n=37)
Total
(n=104)
Cauc
(n=85)
DR1
DR2
DR3
DR4
DR5
DR6
DR7
DR8
DR9
DR10
         61*
52
6
17
8
-
         52**
-
-
2
60
53
5
13
10
-
          55***
-
-
3
21
40
21
17
36
14
17
6
2
2
24
40
19
22
30
16
19
8
-
3
29
38
27
22
21
6
20
2
1
1
28
40
32
20
21
7
22
2
1
1
   * pc = 0.036; RR = 3.83; EF = 0.45
 ** pc = 0.016; RR = 4.31; EF = 0.40
*** pc = 0.017; RR = 4.29; EF = 0.40
Haplotypes HLA-B/DR (number of individuals)
B7/DR7
B12/DR7
B12/DR1
13 ÿ
17 ÿ
26 ÿ
15 ÿ
21 ÿ
31 ÿ
6 ÿ
4
2
8
3
5
1
2
3
1
2
3
ÿ p < 0.004
Table IV - Frequency of HLA-B7 and non-HLA-B7 antigens between HLA-DR7 positive and
negative individuals, and frequency of HLA-DR7 and non-HLA-DR7 antigens between HLA-
B7 positive and negative individuals. The number of individuals from the total group and
from  the Caucasoid group is indicated in square brackets. The calculation of the relative
risk and of the p value among individuals with and those without the HLA marker is also
shown. Numbers in parentheses refer to the estimation of the RR and p values for
individuals in whom the HLA marker was absent
Number of individual
in which HLA-B7 is:Populations
Present Absent RR P
HLA-B7+ SSNS
HLA-B7+ Control
HLA-B7- SSNS
HLA-B7- Control
7 [7]
1 [1]
16 [13]
20 [18]
11 [11]
15 [13]
12 [7]
68 [53]
9.5 (8.3)
4.5 (5.5)
0.04 (0.01)
0.002 (0.001)
Number of individual
in which HLA-B7 is:
Present Absent RR p
HLA-DR7+ SSNS
HLA-DR7+ Control
HLA-DR7- SSNS
HLA-DR7- Control
7 [6]
1 [1]
11 [8]
15 [13]
16 [14]
20 [18]
12 [10]
68 [53]
8.7 (7.7)
4.1 (3.3)
0.02 (0.09)
0.005 (0.01)
SSNS - steroid-sensitive nephrotic syndrome
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4. DISCUSSION
Since there is possibility of transition from MCD
to FSGC, and since these two varieties of idiopathic
nephrotic syndrome share immunological abnormali-
ties, it is possible that the presentation of one variety
or the other may depend upon immunogenetic mark-
ers. Most of the studies on HLA antigens have inves-
tigated the frequency of these antigens in these two
conditions usually considered together. In this study,
we have characterized serological HLA typing of pa-
tients presenting with SSNS or FSGC in a Brazilian
population from the Northeast region of the State of
São Paulo.
Although we did not find any significant associ-
ation of HLA-A or -B antigens with SSNS or FSGC,
some studies have reported association of HLA-B8
and HLA-B12 (including splits HLA-B44 and -B45),
and HLA-B13 in English(21), South African(22), German
and Irish children with SSNS(12,23,24). In contrast, HLA-
A28 and HLA-B12 have been associated with FSGC
in North American Black or White children and in
German children(12,15,25). On the other hand, studies
conducted on French or Japanese children with
SSNS(13,14,26), and on White or Black North American
patients with FSGC(27) have not shown any associati-
on with HLA-A or -B antigens.
HLA-DR7 specificity and the HLA-B7/DR7
haplotype were overrepresented in our series of pa-
tients with SSNS, both when considering the whole
group or just the Caucasoid group. Since HLA-B7 is
in linkage disequilibrium with HLA-DR7 in the Brazil-
ian population(20), we next determined whether the
susceptibility conferred by these antigens was depen-
dent on this linkage disequilibrium. In order to detect
the strongest association, we estimated the RR and
EF for HLA-B7 (3.51 and 0.28, respectively) and
for HLA-DR7 (4.31 and 0.40, respectively). In addi-
tion, we evaluated the presence of HLA-B7 antigen
in patients and controls possessing or not the HLA-
DR7 antigen, and the presence of HLA-DR7 in pa-
tients and controls possessing or not the HLA-B7 speci-
ficity (Table IV). Considering that, in all the combina-
tions of HLA-B7/DR7 antigens studied, the RR and
EF were high for both antigens, we concluded that
these susceptibility markers were independent. There
are several reports showing increased frequency of
HLA-DR7 antigen in children with SSNS of distinct
ethnic background, i. e., Australian(28), French(13,14,17),
Spanish(29), German(15/17), English(30), North Ameri-
can(31) and Chinese children(32), whereas HLA-DR8
antigen is observed only in adult Japanese patients(33).
In addition, HLA-DQ2 antigen and the combination
o f
HLA-DR3/DR7 antigens have also been positively
associated with SSNS, whereas HLA-DR2, -DR6
and -DQ1 have been negatively associated with SSNS
in children of French and German ancestry(17). Besides
serological HLA typing, restriction fragment length poly-
morphism typing of HLA*DRB and *DQB
genes has also indicated increased frequency of HLA-
DRB1*0701 and HLA-DQB1*0201 alleles in French,
German and English patients with SSNS (16,17,30). On
the other hand, HLA-DR3 antigen and the HLA-DR3/
DR7 or HLA-B8/DR3/DR7 combinations have been
associated with steroid-resistant nephrotic syndrome
in French and German children(14,15,17). In addition to
HLA-DR7 and HLA-DR1 antigen, the combination
of HLA-DR1/DR7 antigens was also overrepresented
in our series of SSNS patients as the whole group.
Since HLA-DR1 has never been previously associ-
ated with SSNS, this specificity could be a character-
istic marker for SSNS in this Brazilian population.
Although neither HLA-B7 nor HLA-DR7 anti-
gens were increased in FSGC patients (total group or
only Caucasoids), the frequency of haplotype HLA-
B7/DR7 was significantly increased in relation to the
control population. There are few studies evaluating
HLA antigens exclusively in patients with FSGC. Fam-
ily studies conducted on Hispanic(34) and Australian(35)
siblings with FSGC have indicated the presence of
HLA-DR8 and HLA-DR3/DR7 antigens, respectively.
In unrelated patients, Glicklich et al. (25) reported an
increased frequency of HLA-DR4 antigen in both
White and Black North American patients with idio-
pathic FSGC. Freedman et al.(27), studying 605 renal
transplant recipients with renal failure due to FSGC,
detected no significant association with HLA-DR an-
tigens in African Americans or Caucasian patients. Al-
though these authors did not mention whether the pa-
tients had idiopathic or secondary FSGC, their results
are similar to ours. In contrast, Gerbase-de-Lima(36)
studying 19 Brazilian patients from the city of São Paulo
presenting with FSGS (16 White and 3 of Japanese
origin) found an association with HLA-DR4 antigen.
The non-observation of significant association with
HLA-DR antigens, as reported in this study,  did not
mean absence of association. Perhaps the study of
HLA-DQ and DP specificities may disclose such an
association. The comparative immunophenotyping of
53
HLA and idiopathic nephrotic syndrome
kidney biopsies from normal versus FSGC individuals
revealed a reduction of HLA class II antigens along
with increased CD8-positive lymphocytes in sclerotic
glomeruli, and an abnormal expression of HLA-DQ
and -DP antigens in proximal tubular epithelial cells
together with increased numbers of interstitial CD4-
positive lymphocytes(37), suggesting the participation
of HLA-DQ and -DP molecules in the pathogenesis
of FSGC.
In conclusion, even though the genetic features
of the Brazilian population are non-homogeneous, our
series of patients with SSNS (total group or only
Caucasoids) presented an immunogenetic marker
(HLA-DR7) which is similar to that observed in more
homogeneous Caucasoid populations reported in the
literature. In addition, the haplotype HLA-B7/DR7,
HLA-DR1 antigen and the combination of HLA-DR1/
DR7 antigens may represent peculiar immunogenetic
markers for SSNS Brazilian patients. In contrast, patients
with FSGC presented no detectable HLA-A, -B or -DR
antigen association; however, the HLA-B7/DR7
haplotype was also overrepresented in this series.
Therefore, besides immunologic and pathogenic
features, SSNS and FSGC also share increased
frequency of the  HLA-B7/DR7 haplotype. Although
there are some diseases defined as idiopathic nephrotic
syndrome, they may represent different stages of a
single disease, depending on the immunogenetic
background of the patient. Certainly, this subject
deserves further investigation. The study of the major
histocompatibility complex alleles at the molecular level
may identify susceptibility/protective genes responsible
for the association of HLA and idiopathic nephrotic
syndrome.
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